Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Propanc Biopharma Inc
PPCBCurrent price
0.0004 USD
+0.0001 USD (+33.33%)
Last closed
0.0003 USD
Company
www.propanc.com
ISIN
US74346N4043
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
206 406 USD
Yield for 12 month
-97.20 %
1Y
3Y
5Y
10Y
15Y
PPCB
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Address: 302, 6 Butler Street, Camberwell, VIC, Australia, 3124
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.52 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-34 150 USD
Last Year
-28 841 USD
Current Quarter
-5 764 USD
Last Quarter
-4 773 USD
Key Figures PPCB
1 year
3 years
5 years
10 years
EBITDA
-1 535 752 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1447.01 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
1.52 USD
Revenue TTM
–
Book Value
-0.008 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.02 USD
Diluted Eps TTM
-0.02 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PPCB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PPCB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:1000
Payout Ratio
–
Last Split Date
19.11.2020
Dividend Date
19.11.2020
Stock Valuation PPCB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.5488
Price Book MRQ
–
Financials PPCB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PPCB
For 52 weeks
0.0002 USD
0.021 USD
50 Day MA
0.0004 USD
Shares Short Prior Month
–
200 Day MA
0.0018 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart